Danong Chen has been elected as the new president and CEO of Theranostics Health. Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company that was acquired by Genentech in 2007.
Prior to her tenure at Tanox she served as a manager in the health care practice section at Arthur D. Little. Chen also holds a PhD from Baylor College of Medicine as well as an MBA from Arthur D. Little School of Management in Boston.